IGMS (igmbio.com) Sof foyda

IGMS (igmbio.com) - kompaniyaning tovar belgisi

IGM Biosciences, Inc. (IGMS) saratonga qarshi antitanalarni ishlab chiqish uchun robotlashtirilgan skriningni joriy qilmoqda, bu esa inson omili tufayli yuzaga keladigan xatoliklarni minimallashtiradi. Kompaniyaning tijorat natijalari hosildorlik dinamikasini aniq namoyish etadi, bunda -0.05 qiymati ushbu metrikani aks ettiradi. Biologik preparatlarning xavfsizligi o'ta ishonchli sovuq zanjir logistikasi orqali ta'minlanadi. Shu bilan birga, rahbariyat o'zining R&D yadrosi rivojlantirilishini avtoimmun patologiya terapiyalarining istiqbolli bozoriga muvaffaqiyatli yo'naltirdi.

IGMS (IGM Biosciences, Inc.) Sof foyda tarixi 04.07.2022dan 24.08.2025gacha

igmbio.com (IGMS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari IGM Biosciences|IGMS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi IGM Biosciences, Inc.|IGMS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati IGM Biosciences|IGMS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi igmbio.com|IGMS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati IGM Biosciences, Inc.|IGMS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati IGM Biosciences|IGMS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar IGM Biosciences, Inc.|IGMS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi IGM Biosciences|Shoshilinch likvidlik igmbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IGMS - Sof foyda
Kompaniyaning jamlanma tahlili:IGM Biosciences, Inc.
IGM Biosciences Inc. asosiy tovari

IGM Biosciences, Inc. (IGMS) kompaniyasining sof iqtisodiy effekt dinamikasi naqd pul oqimlarining haqiqiy tezligini aks ettiradi va haqiqiy foydani kunlik monitoring qilish orqali an'anaviy hisobotlarning vaqt kechikishini neytrallaydi. Ushbu metrika biznesning joriy operatsion rentabelligini o'lchaydi, bu esa investorlarga platformaning autoimmun kasalliklar sari yo'nalishini o'zgartirishi sharoitida R&D xarajatlarining samaradorligini baholash imkonini beradi, aktivlarning bozor qiymati esa mavjud naqd pul zaxiralarini allaqachon hisobga olgan.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|NKTR: Sof foyda|Yillik sof foyda upstreambio.com UPB|Kompaniyaning sof foydasi Zenas Biopharma|Sof daromad Immunome Inc (IMNM)|Sof daromad GOSS (Gossamer Corp)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Astria Corp (ATXS)|Kompaniyaning sof foydasi enGene Holdings Inc.|rapt.com (RAPT) - Sof moliyaviy natija|Sof foyda JBIO|Sof daromad Aclaris Therapeutics Inc. ACRS|Sof foyda KYTX (Kyverna)|Sof moliyaviy natija Tiziana Life Sciences, Ltd. (TLSA)|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Kompaniya foydasi AVTX|ELDN (Eledon) - Sof foyda|Sof daromad Agenus, Inc (AGEN)|Sof foyda CLYM|ZURA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi aTyr Pharma ATYR|Sof moliyaviy natija Adagene Inc (ADAG)|IMA: Sof daromad|Yakuniy foyda STTK (Shattuck Labs, Inc.)|EQ: Sof foyda|CNTB - Sof moliyaviy natija|Kompaniyaning sof foydasi Immunic Therapeutics|Kompaniya foydasi ATRA (Atara Biotherapeutics Inc)|Sof foyda IFRX|Sof daromad X4 Pharmaceuticals, Inc XFOR|Adicet Bio, Inc. - Sof daromad|Sof moliyaviy natija Celularity Inc (CELU)|INmune Bio - Sof foyda|Sof moliyaviy natija Barinthus Biotherapeutics PLC BRNS|KZR: Sof foyda|Yillik sof foyda SAB Biotherapeutics Inc SABS|Kompaniyaning sof foydasi Akari Therapeutics|Sof daromad Enlivex Therapeutics, Ltd. (ENLV)|Kompaniyaning sof foydasi Q32 Bio Inc. (QTTB)|Sof moliyaviy natija GeoVax Labs|Kompaniyaning sof foydasi Edesa EDSA|IBIO (iBio Corporation) - Soliqdan keyingi foyda|Carisma Tx - Sof foyda|Yakuniy foyda XTLB (xtlbio.com)|BOLT: Sof foyda|HCW Biologics (HCWB) - Sof foyda|Kompaniyaning sof foydasi Aptevo Therapeutics, Inc.|AIM: Yakuniy foyda|Kompaniyaning sof foydasi Aditxt (ADTX)|Sof daromad gribio.com GRI|Sof foyda XRTX (XORTX Therapeutics)|Sof foyda Vyome Holdings Inc. HIND|REVB: Sof daromad|Yakuniy foyda INDP (Indaptus Corp)|SCNI: Sof foyda|CALI - Sof moliyaviy natija|Kompaniyaning sof foydasi Affimed NV|Sof daromad Allakos Therapeutics (ALLK)|Kompaniyaning sof foydasi HOOKIPA Pharma Inc. (HOOK)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi